Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator.
Conventional activators of the fibrinolytic system used for coronary thrombolysis entail unavoidable delay, risk of bleeding, or both in contrast to tissue-type plasminogen activator (t-PA). Because the potential benefit of coronary thrombolysis is inversely related to the duration of antecedent isc...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
1985
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC397976/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3858878/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.82.12.4258 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|